enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Genzyme - Wikipedia

   en.wikipedia.org/wiki/Genzyme

   Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi .

3. Sanofi - Wikipedia

   en.wikipedia.org/wiki/Sanofi

   Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

4. Alemtuzumab - Wikipedia

   en.wikipedia.org/wiki/Alemtuzumab

   Campath as a medication was first approved for B-cell chronic lymphocytic leukemia in 2001. It is marketed by Genzyme, which acquired the worldwide rights from Bayer AG in 2009. Genzyme was bought by Sanofi in 2011. In August/September 2012 Campath was withdrawn from the markets in the US and EU.

5. Sanofi to Buy Genzyme in $20.1 Billion Deal - AOL

   www.aol.com/news/2011-02-16-sanofi-to-buy...

   French drug company Sanofi-Aventis (SNY) has finally made a deal to buy biotech company Genzyme (GENZ) for $20.1 billion, about $74 a share. Genzyme shareholders will get a contingent value right ...

6. Sanofi-Aventis, Genzyme Are on the Brink of a Merger - AOL

   www.aol.com/news/2011-02-07-sanofi-aventis...

   It seems that months of contentious merger talks between French pharmaceutical company Sanofi-Aventis (SNY) and U.S. biotech Genzyme (GENZ) have entered the home stretch. Sanofi is expected to ...

7. Genzyme Officially Rejects Sanofi-Aventis's Takeover Bid - AOL

   www.aol.com/2010/08/30/genzyme-officially...

   One of the most interesting merger and acquisition sagas of the past month is no doubt the French drugmaker Sanofi-Aventis' (SNY) courtship of rare-disease biotech Genzyme (GENZ). On Monday ...

8. Henri Termeer - Wikipedia

   en.wikipedia.org/wiki/Henri_Termeer

   Genzyme was fined $175 million by the FDA for manufacturing deficiencies. [39] Genzymes's competitors benefited [39] and Genzyme stocks fell. As a result, 2011 Genzyme was acquired by Sanofi in an hostile takeover in October 2011—engineered in part by then-CEO of Sanofi, Christopher Viehbacher— [40]: 219 for more than $20 billion. Termeer ...

9. Sanofi-Aventis Opens Buyout Talks with Genzyme - AOL

   www.aol.com/2010/08/03/sanofi-aventis-takeover...

   French pharmaceutical giant Sanofi-Aventis (SNY) sent a letter to major U.S. biotech firm Genzyme (GENZ) proposing a friendly takeover valued at $69 a share, or $18.4 billion, several media ...